Study shows eye drops useful in preventing glaucoma

June 13, 2002

HOUSTON--(June 13, 2002)--Eye drops used to treat elevated pressure inside the eye have been found to be effective in delaying the onset of primary open-angle glaucoma, the most common form of the disease that can go undetected for years.

Results of the five-year study were published in the June 2002 issue of Archives of Ophthalmology.

"There are several risk factors linked to the development of glaucoma, and this study has helped us to define how much benefit we can provide by decreasing eye pressure with eye drops," said Dr. Ronald L. Gross, a professor of ophthalmology at Baylor College of Medicine in Houston and an investigator in the study.

Open-angle glaucoma is one of the leading causes of blindness in the United States and the number one cause of blindness among African Americans. The disease often occurs when fluid builds up, causing pressure in the eye to increase. When this pressure damages the optic nerve, glaucoma and vision loss are the result.

The National Ocular Hypertension Treatment study evaluated 1,636 people ranging in age from 40-80 with elevated pressure in the eye, with no signs of glaucoma damage. Half received daily eye drops, while the other half were given no medication. For those who received the medication, eye pressure decreased by approximately 20 percent.

Researchers found that the risk for developing primary open-angle glaucoma was cut by more than 50 percent for those individuals who used the eye drops. The study showed that 4.4 percent of the study participants receiving the drops developed glaucoma over a five-year period, while 9.5 percent of the participants who did not receive the drops developed glaucoma. Additionally, study participants with several risk factors were found to be more likely to develop the disease. These included age, race, and a family history of glaucoma, as well as ocular risk factors including elevated eye pressure, corneal thinness and certain characteristics in the anatomy of the optic nerve.

"Glacoma is often referred to as the 'sneak thief of sight' because it often occurs with no pain or symptoms," said Gross, also the Clifton R. McMichael chair of ophthalmology at Baylor. "Many times patients don't notice a difference in peripheral vision until the problem has progressed, therefore, it is essential to visit an ophthalmologist to detect the condition early."
-end-
The 22-center study was supported by the National Eye Institute, The National Center on Minority Health and Health Disparities, Research to Prevent Blindness and Merck Research Laboratories.

Baylor College of Medicine

Related Glaucoma Articles from Brightsurf:

Monitoring glaucoma at home
Glaucoma is a chronic condition that affects cells at the back of the eye.

Study finds novel mechanism that may confer protection against glaucoma
A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associated with glaucoma.

AI-supported test for very early signs of glaucoma progression
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.

New method gives glaucoma researchers control over eye pressure
Neuroscientists have developed a new method that permits continuous regulation of eye pressure without damage, becoming the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.

Glaucoma care in prison inmates
Data fromĀ 82 prison inmates treated in a glaucoma clinic at an academic hospital were used in this observational study to report on how treatment and follow-up, including medication adherence, were are managed.

New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

Air pollution linked to higher glaucoma risk
Living in a more polluted area is associated with a greater likelihood of having glaucoma, a debilitating eye condition that can cause blindness, finds a new UCL-led study in the UK.

Long-term statin use associated with lower glaucoma risk
A new study brings the connection between statin use and risk of glaucoma into sharper focus.

Health burden of glaucoma has risen worldwide
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.

UAlberta scientists first to pinpoint a cause of pigmentary glaucoma
An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition.

Read More: Glaucoma News and Glaucoma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.